Shen Yin

1.6k citations
34 papers · 1.1k indexed · 1 hit paper · h-index 14
Topics
CAR-T cell therapy research (14 papers)Lymphoma Diagnosis and Treatment (10 papers)Monoclonal and Polyclonal Antibodies Research (9 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood

In The Last Decade

Shen Yin

30 papers receiving 1.0k citations

Hit Papers

Safety and efficacy of mosunetuzumab, a bispecific antibo...2022202620232024202250100150200

Peers

Shen Yin
Comparison fields: 5 of 81
  • Oncology 705
  • Pathology and Forensic Medicine 631
  • Molecular Biology 233
  • Radiology, Nuclear Medicine and Imaging 224
  • Immunology 195
Replace Genevive Hernandez with:
Genevive Hernandez United States
Jeff Wiezorek United States
Keiichiro Honma Japan
Amanda Copeland United States
Laura Casorzo Italy
Karin Havenith United States
Oliver Weigert Germany
Vittoria Martin Switzerland
Blanca González‐Farré Spain
Shen Yin relative to Genevive Hernandez United States Genevive Hernandez's profile →
Citations per field
00.5×10×
Genevive Hernandez · 1×
Citations per year

Countries citing papers authored by Shen Yin

Since Specialization
Citations

This map shows the geographic impact of Shen Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shen Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shen Yin more than expected).

Fields of papers citing papers by Shen Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shen Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shen Yin. The network helps show where Shen Yin may publish in the future.

Co-authorship network of co-authors of Shen Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Shen Yin. A scholar is included among the top collaborators of Shen Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shen Yin. Shen Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 34
3 4
4 6
5 5
6 34
7 5
8 0
9 44
10 0
11 1
12 14
13 8
14
Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 studybreakdown →
244
15 27
16
Mitochondria P-glycoprotein confers paclitaxel resistance on ovarian cancer cells
1
17 44
18 2
19 21
20 9

About Shen Yin

Shen Yin is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology, having authored 34 papers that have together received 1.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (14 papers), Lymphoma Diagnosis and Treatment (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). The work is most often cited by research in Pathology and Forensic Medicine (631 citations), Oncology (705 citations) and Genetics (129 citations). Shen Yin has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Michael C. Wei, Lihua E. Budde, Nancy L. Bartlett, Sarit Assouline, Asad Umar, John I. Risinger, J. Carl Barrett, J. Russell Lipford, Michael Kane and Jayne C. Boyer. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026